Debora Collotta, and Massimo Collino. 2016. “NLRP3 Inflammasome Signaling Platform As New Pharmacological Target for Metaflammation”. Diabetes Research 3 (1):e1-e3. https://doi.org/10.17140/DROJ-3-e008.